# Lupin Launches Raltegravir Tablets, USP, 600 mg in the United States

- Source: PR Newswire M&A
- Published: 2026-11-03T15:46:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/lupin-launches-raltegravir-tablets-usp-600-mg-in-the-united-states-302928039.html
- Canonical: https://groundlevelnews.com/story/lupin-launches-raltegravir-tablets-usp-600-mg-in-the-united-states-eba55b/

As the First-To-File, Lupin is Eligible for 180-Day Generic Exclusivity MUMBAI, India and NAPLES, Fla., Nov. 3, 2026 /PRNewswire/ -- Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced the launch of...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._